SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rosetta Inpharmatics (RSTA) -- Ignore unavailable to you. Want to Upgrade?


To: greedsgd_2000 who wrote (7)11/4/2000 12:43:08 AM
From: akoni-1  Read Replies (1) | Respond to of 31
 
Check out the 12/4/00 issue of Red Herring Magazine, currently available online. In articulating the top 10 trends of 2001, the magazine authors discuss biotechnology, including very favorable references to RSTA.

Rosetta is positioned to lead in the evolution of functional genomics. It is described favorably as a "cross between a software company and a pathology lab, working to enable researchers to better predict drug toxicity based on a person's genomic profile".

Akoni